Terms: = Cervical cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
4990 results:
1. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
Buyukbayram ME; Hannarici Z; Turhan A; Caglar AA; Esdur PÇ; Bilici M; Tekin SB; Erdemci B
BMC Cancer; 2024 May; 24(1):626. PubMed ID: 38783223
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study.
Traore B; Kassogue Y; Diakite B; Diarra F; Cisse K; Kassogue O; Diarra M; Coulibaly A; Coulibaly B; Diallo H; Diarra Z; Ly M; Maiga A; Sissoko SB; Sissoko AS; Traore CB; Kamate B; Teguete I; Bah S; Dolo G; Gursel DB; Holl J; Hou L; Maiga M
BMC Infect Dis; 2024 May; 24(1):513. PubMed ID: 38778266
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
4. Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the 'adjusted dose score'.
Miyata Y; Ogo E; Murotani K; Tsuda N; Suzuki G; Tsuji C; Akeda R; Muraki K; Hattori C; Abe T
J Radiat Res; 2024 May; 65(3):393-401. PubMed ID: 38739893
[TBL] [Abstract] [Full Text] [Related]
5. HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
Pasquier C; Raymond S; Carcenac R; Demmou S; Ranger N; Nicot F; Izopet J
J Med Virol; 2024 May; 96(5):e29652. PubMed ID: 38727029
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
[TBL] [Abstract] [Full Text] [Related]
7. Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study.
Dvořák V; Petráš M; Dvořák V; Lomozová D; Dlouhý P; Králová Lesná I; Pilka R
Hum Vaccin Immunother; 2024 Dec; 20(1):2343552. PubMed ID: 38723789
[TBL] [Abstract] [Full Text] [Related]
8. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
[TBL] [Abstract] [Full Text] [Related]
9. Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer-A prospective study.
Vemula Venkata VL; Hulikal N; Chowhan AK
Cancer Treat Res Commun; 2024; 39():100816. PubMed ID: 38714022
[TBL] [Abstract] [Full Text] [Related]
10. Sexual Orientation and cervical cancer Screening Among Cisgender Women.
Baumann K; Matzke H; Peterson CE; Geller S; Flores R; Prachand NG; Holt HK
JAMA Netw Open; 2024 May; 7(5):e248886. PubMed ID: 38709536
[TBL] [Abstract] [Full Text] [Related]
11. Head-to-head comparison of [
Ji M; Ma G; Liu C; Gu B; Du X; Ou X; Xu X; Song S; Yang Z
Cancer Imaging; 2024 May; 24(1):56. PubMed ID: 38702821
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
13. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
[TBL] [Abstract] [Full Text] [Related]
15. Projected Time for the Elimination of cervical cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study.
Chen YC; Chen YY; Su SY; Jhuang JR; Chiang CJ; Yang YW; Lin LJ; Wu CC; Lee WC
JMIR Public Health Surveill; 2024 Apr; 10():e46360. PubMed ID: 38635315
[TBL] [Abstract] [Full Text] [Related]
16. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
Xu M; Lin MC; Li ZH
BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
[TBL] [Abstract] [Full Text] [Related]
17. Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
Li W; Ma L; Li F; Li K; Zhang Y; Ren H; Bao X; Guo Y; Guo Y; Wang M; Li D; Duan Y; Ma X; Wang Z; Wang Y; Yin R
Radiat Oncol; 2024 Apr; 19(1):46. PubMed ID: 38594678
[TBL] [Abstract] [Full Text] [Related]
18. A Comparative Study of Deep Learning Dose Prediction Models for cervical cancer Volumetric Modulated Arc Therapy.
Wu Z; Liu M; Pang Y; Deng L; Yang Y; Wu Y
Technol Cancer Res Treat; 2024; 23():15330338241242654. PubMed ID: 38584413
[No Abstract] [Full Text] [Related]
19. High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
Liu P; Yang X; Zhao H; Liang L; Chen M; Yin A
Hum Vaccin Immunother; 2024 Dec; 20(1):2337161. PubMed ID: 38566539
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
Li Z; Zhou G; Jiang L; Wang M
BMC Cancer; 2024 Apr; 24(1):401. PubMed ID: 38561685
[TBL] [Abstract] [Full Text] [Related]
[Next]
